(Q81241464)
Statements
A new case with rare e6a2 BCR-ABL fusion transcript developing two new resistance mutations during imatinib mesylate, which were replaced by T315I after subsequent dasatinib treatment (English)
S Schnittger
U Bacher
W Kern
T Haferlach
B Hertenstein
13 September 2007